NIMble innovation—a networked model for public antibiotic trials
Summary: Antibiotic research and development is at an inflection point. Faced with ongoing problems with commercial innovation, we argue for a networked public approach to support and coordinate existing research and development initiatives by sustainably moving promising compounds through clinical...
Guardado en:
Autores principales: | Rebecca E Glover, PhD, Andrew C Singer, PhD, Adam P Roberts, PhD, Claas Kirchhelle, PhD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aacf5652e8a54576992a5c2ec4b50189 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study
por: Mark S Pearson, PhD, et al.
Publicado: (2021) -
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study
por: Helen Cox, ProfPhD, et al.
Publicado: (2021) -
The urgent need of public policies for promoting cardiovascular health in Latin-American women
por: Pamela Seron, Ph.D, et al.
Publicado: (2021) -
Key parameters for genomics-based real-time detection and tracking of multidrug-resistant bacteria: a systematic analysis
por: Claire L Gorrie, PhD, et al.
Publicado: (2021) -
Identification and Ranking of Effective Factors on Stock Return Synchronicity Using Neural Networks and Decision Tree Model
por: Mohsen Lotfi (Ph.D), et al.
Publicado: (2019)